Orange Book product · Brand (NDA)

DUAVEE

BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED

Brand (NDA)NDA 022247RX WYETH PHARMS

Oct 03, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Oct 03, 2013
12 yr 11 mo ago
Today
Patent 7683051 expires
Listed drug substance patent expiration.
Mar 10, 2027
in 9 mo
Patent 7683051 expires
Listed drug substance patent expiration.
Mar 10, 2027
in 9 mo

Active ingredient

BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED

Strength

EQ 20MG BASE;0.45MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 022247

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7683051	Mar 10, 2027	in 9 mo	SubstanceProductU-594
7683051	Mar 10, 2027	in 9 mo	SubstanceProductU-904